Metric,First_Complex,Second_Complex
Ligand,TXF,CTX
Total Interactions,378,264
Interaction Difference,,-114
Hydrogen Bonds,6,2
H-Bond Difference,,-4
Non-Bonded (Hydrophobic),330,255
Non-Bonded Difference,,-75
Top Interacting Residues,"PHE 435 (55), ASP 273 (47), LEU 440 (32)","LEU 304 (45), LEU 368 (24), LEU 363 (21)"
Changed Residues,,"LEU 368: First=0, Second=24; ILE 438: First=2, Second=0; PHE 101: First=0, Second=7; TYR 326: First=27, Second=0; ARG 316: First=5, Second=0; MET 364: First=0, Second=12; LEU 97: First=0, Second=3; GLY 356: First=0, Second=1; LEU 388: First=0, Second=9; PRO 317: First=0, Second=4; GLU 275: First=25, Second=0; VAL 313: First=15, Second=0; ALA 431: First=5, Second=0; LEU 271: First=2, Second=0; MET 306: First=7, Second=0; PRO 461: First=0, Second=4; LEU 309: First=21, Second=0; CYS 269: First=22, Second=0; LYS 414: First=0, Second=21; VAL 254: First=0, Second=4; GLU 441: First=7, Second=0; ALA 272: First=24, Second=0; MET 361: First=0, Second=8; LEU 449: First=2, Second=0; LEU 342: First=8, Second=0; LEU 345: First=6, Second=0; PHE 435: First=55, Second=0; TRP 357: First=0, Second=12; LEU 318: First=0, Second=4; SER 221: First=0, Second=12; SER 369: First=0, Second=13; TYR 366: First=0, Second=1; GLY 142: First=0, Second=8; HIS 468: First=0, Second=14; PHE 303: First=0, Second=1; LEU 440: First=32, Second=0; HIS 434: First=10, Second=0; LEU 268: First=14, Second=0; LEU 363: First=0, Second=21; ILE 359: First=0, Second=3; GLY 143: First=0, Second=6; SER 305: First=0, Second=6; LEU 418: First=0, Second=2; MET 446: First=2, Second=0; ILE 349: First=9, Second=0; TRP 305: First=8, Second=0; GLY 371: First=0, Second=7; PRO 360: First=0, Second=8; LEU 304: First=0, Second=45; LEU 358: First=0, Second=3; ALA 93: First=0, Second=1; ASP 273: First=47, Second=0; LEU 265: First=4, Second=0; ASN 346: First=19, Second=0"
H-Bond Residues,ASP 273,LEU 363
Binding Insight,Hydrophobic dominate (98.2%),Hydrophobic dominate (99.2%)
